Stock Events

Stock Events

Alnylam Pharmaceuticals (A1LN34.SA) Q4 2019 Earnings

31OctConfirmed

Q1 2019

Q2 2019

Q3 2019

Q4 2019

-8.54

-7.96

-7.37

-6.78

Details

Expected EPS

-8.0324

Actual EPS

-7.711104000000001

Surprise EPS

0.32

Surprise Percent

+4%

Description

Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of -7.711104000000001 per share for Q4 2019.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.